REGENXBIO  logo
REGENXBIO RGNX
$ 9.3 2.88%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

REGENXBIO Gross Profit 2011-2026 | RGNX

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit REGENXBIO

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 27 M 209 M 8.68 M 3.63 M 6.08 M 5.11 M 5.76 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
209 M 3.63 M 37.9 M

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA
BioCardia BioCardia
BCDA
141 K $ 1.37 6.2 % $ 29 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
19.7 M $ 2.8 -1.06 % $ 908 M israelIsrael
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
24.3 $ 1.64 -1.8 % $ 4.16 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Cabaletta Bio Cabaletta Bio
CABA
0.006 $ 3.34 0.6 % $ 3.9 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Codexis Codexis
CDXS
52.8 M $ 1.05 3.47 % $ 77.1 M usaUSA
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.6 1.56 % $ 480 M usaUSA
Certara Certara
CERT
129 M $ 7.17 1.27 % $ 1.15 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
19.9 M $ 2.28 25.97 % $ 204 M israelIsrael
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Coherus BioSciences Coherus BioSciences
CHRS
339 M $ 1.66 -0.9 % $ 156 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
2.32 M - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
AIkido Pharma AIkido Pharma
AIKI
10 K - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
37.7 M $ 3.88 - $ 116 M franceFrance
Aeterna Zentaris Aeterna Zentaris
AEZS
4.73 M - 5.93 % $ 314 M canadaCanada
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
7.22 M $ 1.02 -0.97 % $ 10.4 M usaUSA
Aptinyx Aptinyx
APTX
1.56 K - -39.0 % $ 4.57 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
128 M $ 42.0 0.79 % $ 1.33 B usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
301 M $ 35.61 -0.25 % $ 3.7 B usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1 K - 17.91 % $ 11.1 M usaUSA